Regenerative Medicine and Stem Cells Technologies

Doctors on Sunday hailed what they say is a major breakthrough in the treatment of multiple sclerosis, halting progress of the disease and relieving symptoms in some patients.

When NASA astronaut Scott Kelly stood up last March after spending a year in space, he was two inches taller than his identical twin brother Mark.

British physicians have successfully used stem cells to repair the degenerating tissue at the back of two patients eyes in a world first, effectively reversing their diminishing eyesight.

An estimated 30.7% of Americans report chronic pain (chronic, recurrent, or long-lasting pain lasting at least 6 months) [1], making it an incredibly common and poorly treated disease state.

Professor Ali Khademhosseini is the recipient of the 2018 Acta Biomaterialia Silver Medal. He is Professor of Medicine at Harvard Medical School and Director of the Biomaterials Innovation Research Center at Brigham and Women’s Hospital. He is also a Faculty member at the Harvard-MIT Division of Health Sciences and Technology as well as an Associate Faculty member at the Wyss Institute for Biologically Inspired Engineering.

A pharmaceutical company based in Osaka, Japan, opened a regenerative medicine center yesterday (March 22) that will produce cells derived from induced pluripotent stem (iPS) cells for commercial applications. The center is the first plant of its kind globally. It will initially produce cells for use in clinical trials.

In its ninth year, The International Théophile Legrand Textile Innovation Awards are being under the auspices of the Fondation de France and coordinated by the Union des Industries Textiles (UIT), the union of textile industries, the employers association representing the diversity of French textile sections and regions. In 2018, two prizes of € 8,000 and € 7,000 will be presented to those textile projects considered to be the most innovative.

The closing ceremony of the second student Olympiad on stem cells and regenerative medicine was held in the Vice-Presidency for science and technology affairs and the winners were awarded

Babies with the rare, deadly genetic disorder Sandhoff disease begin to miss developmental milestones just months after birth. Lacking muscle tone, they never learn to sit up, develop heads too large to lift and eventually suffer uncontrollable seizures. There is no cure

Gene therapies promise to revolutionize the treatment of many diseases, including neurological diseases such as ALS. But the small viruses that deliver therapeutic genes can have adverse side effects at high doses. UNC School of Medicine researchers have now found a structure on these viruses that makes them better at crossing from the bloodstream into the brain – a key factor for administering gene therapies at lower doses for treating brain and spinal disorders.